There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.
Micah Cost, PharmD, MS, Chief Executive Officer, Pharmacy Quality Alliance
Advertisement
Articles by Micah Cost, PharmD, MS, Chief Executive Officer, Pharmacy Quality Alliance
Pharmacy Quality Alliance's new benchmark evaluates adherence to medications for diabetes, high cholesterol, and hypertension.
New composite pharmacy adherence measure is a major step in developing standard pharmacy performance measures focused on improving patient care.
Pharmacy performance measures can support greater patient access to care and services through team-based care and to facilitate value-based contracts between pharmacists and payers.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Expands Approval of Sotatercept-csrk for Pulmonary Arterial Hypertension
2
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
3
Clinical Data Support Use of Low-Carbon Version of Albuterol Metered Dose Inhaler for Asthma
4
Study Shows Growing Confidence in Cell and Gene Therapies Across the Care Continuum
5
